India  
 
NewsR.in

India's first chemo syrup is here, to benefit 10,000 kids a year

IndiaTimes Saturday, 30 December 2023
Doctors from Tata Memorial Centre and IDRS Labs have developed India's first chemotherapy drug, 6-mercaptopurine (6-MP), in a syrup form to combat Acute Lymphoblastic Leukemia (ALL) in children. The oral suspension, called PREVALL, effectively tackles challenges associated with existing tablet formulations. It is expected to benefit around 10,000 children annually. The child-friendly formulation is available as a powder for oral suspension, offering precise dosing tailored to a patient's body. The powder is designed to ensure stability of the drug in hot/humid conditions.
0
shares		ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

You Might Like


Related videos from verified sources

Covid-19: Centre issues advisory to states after first case of JN.1 variant in India | Oneindia [Video]

Covid-19: Centre issues advisory to states after first case of JN.1 variant in India | Oneindia

The Centre has issued a nationwide advisory as the first case of the new coronavirus variant, JN.1, surfaced in India. The Centre has issued a crucial advisory to all states following the detection of..

Credit: Oneindia     Duration: 02:26Published